Az emésztőszervi neuroendokrin daganatok igen változatos klinikai képet okozhatnak. Egyrészt a tumorok által elválasztott biogén aminok, peptidek, hormonok hatására paraneoplasztikus szindrómák alakulhatnak ki, másrészt a hormonálisan inaktív daganatok növekedésükkel okozhatnak igen szerteágazó lokális tüneteket. A tumorok hosszú ideig teljesen tünetmentesek lehetnek, vagy atípusos, gyakran átmeneti tüneteket okozva éveken keresztül nem kerülnek felismerésre, vagy félrediagnosztizálják őket. A döntően pancreaseredetű speciális hormontermelő daganatok klinikai képe jellegzetes, miképpen a betegek 10–18%-ában fellépő carcinoidszindróma is. E tanulmányban a klinikai tünetek tárgyalásán túl a laborvizsgálatok és a képalkotó vizsgálatok is kritikus értékelésre kerülnek. Az utóbbi években ezen a területen a szérum kromogranin-A-meghatározás bevezetése, új vékonybél-vizsgálati módszerek megjelenése jelentette a fejlődés irányát. A kapszulaendoszkópia és a ballonos enteroszkópia számos esetben jóval koraibb diagnózis lehetőségét nyújtja, mint arra korábban mód volt. Az endoszkópos ultrahangvizsgálat és a tűbiopszia elterjedése pedig döntően a pancreas neuroendokrin daganatainak felismerését, pontosabb lokalizálását teszi lehetővé. Orv. Hetil., 2011, 152, 371–378.
Modlin, I. M., Lye, K. D., Kiss, M.: A 5-decade analysis of 13,715 carcinoid tumors. Cancer, 2003, 97, 934–959.
Kiss M. , 'A 5-decade analysis of 13,715 carcinoid tumors ' (2003 ) 97 Cancer : 934 -959 .
Yao, J. C., Hassan, M., Phan, A. és mtsai: One hundred years after „carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the Unites States. J. Clin. Oncol., 2008, 26, 3063–3072.
Phan A. , 'One hundred years after „carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the Unites States ' (2008 ) 26 J. Clin. Oncol. : 3063 -3072 .
Berge, T., Linell, F.: Carcinoid tumors. Frequency in a defined population during a 12-year period. Acta Pathol. Microbiol. Scand. A., 1976, 84, 322–330.
Linell F. , 'Carcinoid tumors. Frequency in a defined population during a 12-year period ' (1976 ) 84 Acta Pathol. Microbiol. Scand. A. : 322 -330 .
Gustafsson, B. I., Kidd, M., Modlin, I. M.: Neuroendocrine tumors of the diffuse neuroendocrine system. Curr. Opin. Oncol., 2008, 20, 1–12.
Modlin I. M. , 'Neuroendocrine tumors of the diffuse neuroendocrine system ' (2008 ) 20 Curr. Opin. Oncol. : 1 -12 .
Maggard, M. A., O’Connell, J. B., Ko, C. Y.: Updated population-based review of carcinoid tumors. Ann. Surg., 2004, 240, 117–122.
Ko C. Y. , 'Updated population-based review of carcinoid tumors ' (2004 ) 240 Ann. Surg. : 117 -122 .
Hassan, M. M., Phan, A., Li, D. és mtsai: Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study. Int. J. Cancer, 2008, 123, 867–873.
Li D. , 'Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study ' (2008 ) 123 Int. J. Cancer : 867 -873 .
Klöppel, G., Perren, A., Heitz, P. U.: The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann. N. Y. Acad. Sci., 2004, 1014, 13–27.
Heitz P. U. , 'The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification ' (2004 ) 1014 Ann. N. Y. Acad. Sci. : 13 -27 .
Nobels, F. R., Kwekkeboom, D. J., Bouillon, R. és mtsa: Chromogranin A: its clinical value as marker of neuroendocrine tumours. Eur. J. Clin. Invest., 1998, 28, 431–440.
Bouillon R. , 'Chromogranin A: its clinical value as marker of neuroendocrine tumours ' (1998 ) 28 Eur. J. Clin. Invest. : 431 -440 .
Rindi, G., Klöppel, G., Alhman, H. és mtsai: TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grading system. Wirchows Arch., 2006, 449, 395–401.
Alhman H. , 'TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grading system ' (2006 ) 449 Wirchows Arch. : 395 -401 .
Rindi, G., Klöppel, G., Couvelard, A. és mtsai: TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Wirchows Arch., 2007, 451, 757–762.
Couvelard A. , 'TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system ' (2007 ) 451 Wirchows Arch. : 757 -762 .
Couvelard, A., Scoazec, J. Y.: A TNM classification for digestive endocrine tumors of midgut and hindgut: proposals from the European Neuroendocrine Tumor Society (ENETS). Ann. Pathol., 2007, 27, 426–432.
Scoazec J. Y. , 'A TNM classification for digestive endocrine tumors of midgut and hindgut: proposals from the European Neuroendocrine Tumor Society (ENETS) ' (2007 ) 27 Ann. Pathol. : 426 -432 .
Pape, U. F., Jann, H., Müller-Nordnorn, J. és mtsai: Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer, 2008, 113, 256–265.
Müller-Nordnorn J. , 'Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors ' (2008 ) 113 Cancer : 256 -265 .
Semelka, R. C., Custodio, C. M., Cem Balci, N. és mtsa: Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. J. Magn. Reson. Imaging, 2000, 11, 141–148.
Cem Balci N. , 'Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI ' (2000 ) 11 J. Magn. Reson. Imaging : 141 -148 .
Rockall, A. G., Reznek, R. H.: Imaging of neuroendocrine tumors (CT/MR/US). Best Pract. Res. Clin. Endocrinol. Metab., 2007, 21, 43–68.
Reznek R. H. , 'Imaging of neuroendocrine tumors (CT/MR/US) ' (2007 ) 21 Best Pract. Res. Clin. Endocrinol. Metab. : 43 -68 .
Boukhman, M. P., Karam, J. M., Shaver, J. és mtsai: Localization of insulinomas. Arch. Surg., 1999, 134, 818–823.
Shaver J. , 'Localization of insulinomas ' (1999 ) 134 Arch. Surg. : 818 -823 .
Zimmer, T., Scherübl, H., Faiss, S. és mtsai: Endoscopic ultrasonography of neuroendocrine tumours. Digestion, 2000, 62, 45–50.
Faiss S. , 'Endoscopic ultrasonography of neuroendocrine tumours ' (2000 ) 62 Digestion : 45 -50 .
Kalafat, H., Mihmanli, I., Saribeyoglu, K. és mtsa: Intraoperative doppler ultrasound: a reliable diagnostic method in insulinoma. Hepatogastroenterology, 2007, 54, 1256–1258.
Saribeyoglu K. , 'Intraoperative doppler ultrasound: a reliable diagnostic method in insulinoma ' (2007 ) 54 Hepatogastroenterology : 1256 -1258 .
Gibril, F., Doppman, J. L., Reynolds, J. C. és mtsai: Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management. J. Clin. Oncol., 1998, 16, 1040–1053.
Reynolds J. C. , 'Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management ' (1998 ) 16 J. Clin. Oncol. : 1040 -1053 .
Buchmann, I., Henze, M., Engelbrecht, S. és mtsai: Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur. J. Nucl. Med. Mol. Imaging, 2007, 34, 1617–1626.
Engelbrecht S. , 'Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours ' (2007 ) 34 Eur. J. Nucl. Med. Mol. Imaging : 1617 -1626 .
Kauhanen, S., Seppanen, M., Minn, H. és mtsai: Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients. J. Clin. Endocrinol. Metab., 2007, 92, 1237–1244.
Minn H. , 'Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients ' (2007 ) 92 J. Clin. Endocrinol. Metab. : 1237 -1244 .
Wiesli, P., Brandle, M., Schmid, C. és mtsai: Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinemic hypoglycemia: potential and limitations. J. Vasc. Interv. Radiol., 2004, 15, 1251–1256.
Schmid C. , 'Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinemic hypoglycemia: potential and limitations ' (2004 ) 15 J. Vasc. Interv. Radiol. : 1251 -1256 .
Modlin, I. M., Drozdov I., Gustafsson, B.: Rectal neuroendocrine: Diagnosis and treatment. In: A century of advances in neuroendocrine tumor biology and treatment. Eds.: Modlin, I. M., Öberg, K. Felsenstein CCCP, Hannover, 2007, 124–133.
Gustafsson B. , '', in A century of advances in neuroendocrine tumor biology and treatment , (2007 ) -.
Solcia, E., Sessa, F., Rindi, G. és mtsai: Pancreatic endocrine tumours: general concepts; non functioning tumours and tumours with uncommon function. In: Endocrine pathology of the gut and pancreas. Ed.: Dayal, Y. CRS Press, Boston, 1991, 105–132.
Rindi G. , '', in Endocrine pathology of the gut and pancreas , (1991 ) -.
Pipeleers-Marichal, M., Somers, G., Willems, G. és mtsai: Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger–Ellison syndrome. N. Engl. J. Med., 1990, 322, 723–727.
Willems G. , 'Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger–Ellison syndrome ' (1990 ) 322 N. Engl. J. Med. : 723 -727 .
Lubensky, I. A., Pack, S., Ault, D. és mtsai: Multiple neuroendocrine tumors of the pancreas in von Hippel–Lindau disease patients: histopathological and molecular genetic analysis. Am. J. Pathol., 1998, 153, 223–231.
Ault D. , 'Multiple neuroendocrine tumors of the pancreas in von Hippel–Lindau disease patients: histopathological and molecular genetic analysis ' (1998 ) 153 Am. J. Pathol. : 223 -231 .
Marcos, H. B., Libutti, S. K., Alexander, H. R. és mtsai: Neuroendocrine tumors of the pancreas in von Hippel–Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison. Radiology, 2002, 225, 751–758.
Alexander H. R. , 'Neuroendocrine tumors of the pancreas in von Hippel–Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison ' (2002 ) 225 Radiology : 751 -758 .
Gumbs, A. A., Moore, P. S., Falconi, M. és mtsai: Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. J. Surg. Oncol., 2002, 81, 45–53.
Falconi M. , 'Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms ' (2002 ) 81 J. Surg. Oncol. : 45 -53 .
Roy, P. K., Venzon, D. J., Shojamanesh, H. és mtsai: Zollinger–Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore), 2000, 79, 379–411.
Shojamanesh H. , 'Zollinger–Ellison syndrome. Clinical presentation in 261 patients ' (2000 ) 79 Medicine (Baltimore) : 379 -411 .
Nikou, G. C., Toubanakis, C., Nikolaou, P. és mtsai: VIPomas: an update in diagnosis and management in a series of 11 patients. Hepatogastroenterology, 2005, 52, 1259–1265.
Nikolaou P. , 'VIPomas: an update in diagnosis and management in a series of 11 patients ' (2005 ) 52 Hepatogastroenterology : 1259 -1265 .
Matuchansky, C., Rambaud, J.: VIPomas and endocrine cholera: clinical presentation, diagnosis, and advances in management. In: Endocrine tumours of the pancreas: Recent advances in research and management. Eds.: Jensen, R. T., Mignon, M. Karger, Basel, 1994, 166–182.
Rambaud J. , '', in Endocrine tumours of the pancreas: Recent advances in research and management , (1994 ) -.
Zhang, M., Xu, X., Shen, Y. és mtsai: Clinical experience in diagnosis and treatment of glucagonoma syndrome. Hepatobiliary Pancreat. Dis. Int., 2004, 3, 473–475.
Shen Y. , 'Clinical experience in diagnosis and treatment of glucagonoma syndrome ' (2004 ) 3 Hepatobiliary Pancreat. Dis. Int. : 473 -475 .